Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024

Stock Information for Apollomics Inc.

Loading

Please wait while we load your information from QuoteMedia.